Julia Schaletzky

1.7k total citations
16 papers, 834 citations indexed

About

Julia Schaletzky is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Julia Schaletzky has authored 16 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Infectious Diseases. Recurrent topics in Julia Schaletzky's work include Cardiomyopathy and Myosin Studies (4 papers), Cardiovascular Effects of Exercise (3 papers) and Viral Infections and Immunology Research (3 papers). Julia Schaletzky is often cited by papers focused on Cardiomyopathy and Myosin Studies (4 papers), Cardiovascular Effects of Exercise (3 papers) and Viral Infections and Immunology Research (3 papers). Julia Schaletzky collaborates with scholars based in United States, United Kingdom and Germany. Julia Schaletzky's co-authors include Francis A. Barr, Benjamin Short, Robert Kopajtich, Christian Preisinger, Tom A. Rapoport, Óscar Lorenzo, Michael J. Clague, Stephen K. Dove, Eddie Wehri and Sapar M. Saparov and has published in prestigious journals such as Nature Communications, Molecular Cell and Circulation Research.

In The Last Decade

Julia Schaletzky

14 papers receiving 823 citations

Peers

Countries citing papers authored by Julia Schaletzky

Since Specialization

Citations

This map shows the geographic impact of Julia Schaletzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Schaletzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Schaletzky more than expected).

Fields of papers citing papers by Julia Schaletzky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Schaletzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Schaletzky. The network helps show where Julia Schaletzky may publish in the future.

Co-authorship network of co-authors of Julia Schaletzky

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Schaletzky. A scholar is included among the top collaborators of Julia Schaletzky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Schaletzky. Julia Schaletzky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Analytical Methodologies for Anti-Infective Orphan Drugs: A Comprehensive Review of FDA Approvals (2013-2023) Part 1 2025 ·Critical Reviews in Analytical Chemistry ·(unknown), (unknown), Julia Schaletzky, (unknown)	0
2	Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy 2024 ·Nature Cardiovascular Research ·James J. Hartman, Darren T. Hwee, Julien Robert‐Paganin, Chih-Yuan Chuang, Eva R. Chin, (unknown), (unknown), (unknown), Preeti Paliwal, Julien Pernier, Saswata S. Sarkar, Julia Schaletzky, Kristine Schauer, (unknown), Jingying Wang, Eddie Wehri, Yangsong Wu, Anne Houdusse, (unknown), Fady I. Malik	29
3	Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design 2023 ·Nature Communications ·(unknown), James P. Robblee, Julien Robert‐Paganin, Daniel Auguin, (unknown), Patricia M. Fagnant, (unknown), Julia Schaletzky, Eddie Wehri, Christoph Mueller‐Dieckmann, Jake Baum, Kathleen M. Trybus, Anne Houdusse	6
4	Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis 2023 ·Cell chemical biology ·Joseph M. Hendricks, (unknown), Eddie Wehri, Zhipeng Li, Melissa A. Roberts, Kirandeep K. Deol, Mike Lange, Irene Otero, Jeremiah D. Momper, Scott J. Dixon, Kirill Bersuker, Julia Schaletzky, James A. Olzmann	65
5	Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication 2023 ·RSC Advances ·(unknown), Eddie Wehri, Rahul K. Suryawanshi, (unknown), (unknown), (unknown), (unknown), Ursula Schulze‐Gahmen, G. Renuka Kumar, Mohammad R. K. Mofrad, Daniel K. Nomura, Mélanie Ott, Julia Schaletzky, Niren Murthy	4
6	MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondii 2023 ·PLoS Biology ·(unknown), (unknown), (unknown), Eddie Wehri, (unknown), (unknown), (unknown), Bruno Martorelli Di Genova, Pramod Kumar Rompikuntal, Martin J. Boulanger, David M. Warshaw, Nicholas J. Westwood, Julia Schaletzky, Gary E. Ward	5
7	SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA 2021 ·PLoS Biology ·Amanda Jack, Luke S. Ferro, Michael J. Trnka, Eddie Wehri, (unknown), (unknown), Douglas Fox, (unknown), Sarah A. Stanley, Julia Schaletzky, Ahmet Yıldız	104
8	A proposed workflow for proactive virus surveillance and prediction of variants for vaccine design 2021 ·PLoS Computational Biology ·(unknown), Christopher J.P. Mathy, Julia Schaletzky	0
9	Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy 2021 ·Journal of Medicinal Chemistry ·Chih-Yuan Chuang, Scott E. Collibee, (unknown), Wenyue Wang, (unknown), Xiaolin Wang, Darren T. Hwee, Yangsong Wu, Jingying Wang, Eva R. Chin, (unknown), (unknown), James J. Hartman, Julia Schaletzky, Eddie Wehri, Laura Robertson, Fady I. Malik, B. Paul Morgan	103
10	Characterization of the Cardiac Myosin Inhibitor CK-3773274: a Potential Therapeutic Approach for Hypertrophic Cardiomyopathy 2020 ·Biophysical Journal ·James J. Hartman, Darren T. Hwee, Jingying Wang, Yangsong Wu, Julia Schaletzky, Preeti Paliwal, Ken Lee, (unknown), Eddie Wehri, (unknown), (unknown), Chih-Yuan Chuang, Eva R. Chin, B. Paul Morgan, Fady I. Malik	8
11	Abstract 332: Pharmacologic Characterization of the Cardiac Myosin Inhibitor, CK-3773274: A Potential Therapeutic Approach for Hypertrophic Cardiomyopathy 2019 ·Circulation Research ·Darren T. Hwee, James J. Hartman, Jingying Wang, Yangsong Wu, Julia Schaletzky, Preeti Paliwal, Ken Lee, (unknown), Eddie Wehri, Chih-Yuan Chuang, B. Paul Morgan, Fady I. Malik, Eva R. Chin	3
12	Determining the Conductance of the SecY Protein Translocation Channel for Small Molecules 2007 ·Molecular Cell ·Sapar M. Saparov, Karl J. Erlandson, Kurt S. Cannon, Julia Schaletzky, Sol Schulman, Tom A. Rapoport, Peter Pohl	80
13	Ribosome Binding of a Single Copy of the SecY Complex: Implications for Protein Translocation 2007 ·Molecular Cell ·Jean‐François Ménétret, Julia Schaletzky, William Clemons, Andrew R. Osborne, Sigrid S. Skånland, Carilee Denison, Steven P. Gygi, Donald S. Kirkpatrick, Eunyong Park, Steven J. Ludtke, Tom A. Rapoport, Christopher W. Akey	75
14	Ribosome Binding to and Dissociation from Translocation Sites of the Endoplasmic Reticulum Membrane 2006 ·Molecular Biology of the Cell ·Julia Schaletzky, Tom A. Rapoport	31
15	Phosphatidylinositol-5-Phosphate Activation and Conserved Substrate Specificity of the Myotubularin Phosphatidylinositol 3-Phosphatases 2003 ·Current Biology ·Julia Schaletzky, Stephen K. Dove, Benjamin Short, Óscar Lorenzo, Michael J. Clague, Francis A. Barr	147
16	The Rab6 GTPase Regulates Recruitment of the Dynactin Complex to Golgi Membranes 2002 ·Current Biology ·Benjamin Short, Christian Preisinger, Julia Schaletzky, Robert Kopajtich, Francis A. Barr	174

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact